US FDA explains clinical study, pre-market requirements for computer-assisted detection devices
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued updated versions of two related guidelines on computer-assisted detection (CADe) devices applied to radiology images and radiology device data. The guidelines explain how manufacturers should design and conduct clinical performance studies, and submit pre-market notification, or 510(k), applications for these products.